KFGK
PRME icon

Keystone Financial Group (Kentucky)’s Prime Medicine PRME Stock Holding History

Keystone Financial Group (Kentucky)’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$614K Buy
166,510
+500
+0.3% +$1.66K 0.04% 294
2026
Q1 		$578K Buy
166,010
+36,345
+28% +$138K 0.04% 271
2025
Q4 		$450K Buy
129,665
+58,810
+83% +$262K 0.03% 273
2025
Q3 		$393K Buy
+70,855
New +$288K 0.03% 273

Other funds holding PRME

Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Keystone Financial Group (Kentucky)'s PRME Position: Q2 2026 in Review

Keystone Financial Group (Kentucky) increased its Prime Medicine (PRME) stake by 0.3% in Q2 2026, buying an estimated $1.66K and bringing the position to 166,510 shares worth $614K. The position accounts for 0.04% of the portfolio, ranked #294.

Keystone Financial Group (Kentucky) first reported a position in PRME in Q3 2025 and has held it in 4 quarters since. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Keystone Financial Group (Kentucky) held 166,510 shares of Prime Medicine worth $614K as of Q2 2026.
  • Keystone Financial Group (Kentucky) bought 500 Prime Medicine shares in Q2 2026, an estimated $1.66K.
  • Prime Medicine made up 0.04% of Keystone Financial Group (Kentucky)'s portfolio in Q2 2026, its #294 holding.
  • Keystone Financial Group (Kentucky) first reported a position in Prime Medicine in Q3 2025 and has held it in 4 quarters since.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Keystone Financial Group (Kentucky)'s 13F filing for Q2 2026, filed 29 Jul 2026.